RegisterHere

Infertility

Friday, December 5, 2014

 08:30 - 10:00
INDUSTRY SYMPOSIUM

  

 10:20 - 11:50
INDUSTRY SYMPOSIUM

  

 12:10 - 13:40
ANTI-MÜLLERIAN HORMONE (AMH) AND INDIVIDUALIZED DOSING FOR OVARIAN STIMULATION FOR IVF
Capsule
The indications for the use of AMH to predict ovarian response keep expanding to test questions such as can AMH be used to individualize treatment to predict pregnancy rate or to select the mode of treatment in PCOS? The refinement of the assay promises to popularize this test even further.
Chairpersons
B.C.J.M. Fauser, Nertherlands
Antonio La Marca, Italy
 

AMH concentration to establish individual gonadotropins dose
Antonio La Marca, Italy
 
Debate: Can AMH predict pregnancy rates better than other markers?
Yes: Dominique de Ziegler, France
No: Scott N. Nelson, UK
Discussion
  AMH in PCOS patients
Didier Dewailly, France

  

 14:30 - 16:00
STIMULATION OR MILD STIMULATION?
Capsule Simple questions such as the intensity of stimulation are still controversial
Chairperson Rene Frydman, France
Eli Y. Adashi, USA
 
Debate: Is low intensity ("mild" or "mini") ovarian stimulation preferable?
Yes: Pasquale Patrizio, USA
No: Nicolas H. Zech, Austria
Discussion
 

Innovative stimulation
Dominique de Ziegler, France
 

Does Vit D have any role in female infertility?
Nicolaos P. Polyzos, Belgium

  

  16:30 - 18:00
THE OVARIAN ZONE WORKSHOP

Reconstructing the ovarian story: Towards a new clinical solution
Capsule

There is a need for more breakthroughs to overcome certain forms of infertility that current ART technologies cannot resolve. The story of the ovary is being told all over again; sensational findings are on the horizon which might widen the treatment options and revolutionize daily practice. So join us as the "renaissance" of ovarian physiology is being unfolded by leading groups with cutting edge science.
Chairpersons
Eli Y. Adashi, USA
Phillippe Bouchard, France
  Ovarian germline replenishment: A constant acorss the evolutionary
Evelyn Tefler, UK
  Mitochondrial replacement therapy
Alison Murdoch, UK
 
Producing gametes from stem cells and somatic cells: How far are we from clinical implementation 
Gerald P. Schatten, USA 

Saturday, December 6, 2014

  8:30 - 10:00
PERICONCEPTIONAL MEDICINE: WHERE REPRODUCTIVE AND FETAL MATERNAL MEDICINE MEET
Capsule  After many years of moving apart, the subspecialties of reproductive medicine and obstetrics are once again interfacing and indeed overlapping. The recognition that perinatal morbidity often has its roots in the periconceptional period is balanced by the increasing awareness of the impact of periconceptional health and interventions, such as nutrition, health and IVF on long-term outcomes. At this interface, the new discipline of periconceptional medicine is emerging. In this joint session, obstetricians and reproductive endocrinologists come together to explore the implications of this new knowledge for clinical practice. 
Chairpersons 

Nick S. Macklon, UK
Haiyan Wang, China
Christopher Griffin, Australia

  Periconceptional medicine and the reproductive endocinologist
Scott N. Nelson, UK
  IVF in the medically complicated patient 
Nick S. Macklon, UK
 
Periconceptional medicine and the obstetrician 
Eric A.P. Steegers,  Netherlands
 
Pre-eclampsia: A periconceptional disease
Bas van Rijn,  UK

 

 10:20 - 11:50
DECREASED OVARIAN RESERVE (DOR)
Capsule
 DOR is a frustrating condition which is associated with lower success rate and very little variation of the response to treatment: Any new hopes?
Chairpersons
Luca Gianaroli, Italy
Deidier Dewailly, France
 
What should be considered poor response? Should we test for low reserve prior to IVF?
Luca Gianaroli, Italy
 
Debate: Can we improve response by increasing the dose of Menotropins?
Yes: Higher dose can stimulate oocytes which need higher FSH threshold
Juan A. Garcia-Velasco, Spain
No: The differences are not dependent on the dose but it is the cycle to cycle variation in response that counts
Pasquale Patrizio, USA
Discussion

Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders
Nikolaos P. Polyzos, Belgium 

 

 

 12:10 - 13:40
INDUSTRY SYMPOSIUM

  

 14:30 - 16:00
INDUSTRY SYMPOSIUM

  

  16:30 - 18:00
FREEZING GAMETE FOR FERTILITY PRESERVATION
Capsule With an improved survival rate in almost all types of cancers, preservation of fertility has become a major concern. What can be offered to preserve fertility in males and females?
Chairperson
Rene Frydman, France
Pasquale Patrizio, USA
 
Fertility preservation in pre-pubertal males
Nathalie Rives, France
 
The future of fertility perservation 
Marie-Madeleine Dolmans, Belgium
 
Medical treatments for gonadal damage
Phillippe Bouchard, France
 
Ovarian follicular preservation in the face of chemotherapy
Jacques Donnez, France

Sunday, December 7, 2014

  8:30 - 10:00
CONTROVERSIAL ISSUES IN BASIC CLINICAL ASPECTS OF ART
Capsule
Expert opinion and audience interaction on clinical issues of ART
Chairpersons
Zion Ben-Rafael, Israel
Rene Frydman, France
Panelists
Juan A. Garcia-Velasco, Spain
Pasquale Patrizio, USA
Nikolaos P. Polyzos, Belgium
Nicolas Zech, Austria
Dominik de Ziegler, France
 
 

Questions to the panel:
Clinical aspects

  1. Treating endometrioma before or after IVF? What are the risks?
  2. Treating fibroids: Do we have proof that myomectomy helps the IVF results?
  3. Any proofs that uterine scratching before iVF works?
  4. High dose FSH in DOR: Is it effective?
  5. OHSS free clinic: Is it realistic? One or many strategies?
  6. LH surge before hCG: Cancel the cycle? Freeze all or continue regularly?
  7. Should we withhold IVF based on female age or BMI?
  8. Should we withhold IVF based on diminished ovarian reserve?
  9. Luteal support: Estrogens, hCG, GnRH COS?

  

  10:30 - 12:00
NEW PARADIGMS IN PCOS
Capsule The most common endocrinopathy remains enigmatic in many of its aspects.
Chairperson
Dominique de Ziegler, France
Pasquale Patrizio, USA
 
An endocrinologist’s view on impaired glucose intolerance in PCOS
Philippe Bouchard, France
 
What do we know about the true cardiovascular risk in PCOS?
Bart C.J.M Fauser, Netherlands
 
How to assess the polycystic ovary: An ultrasound and AMH update
Didier Dewailly, France
 
PCOS during adolescence
Charles Sultan, France